Report cover image

Global Cell Cryoprotectant Market Growth 2025-2031

Published Jun 13, 2025
Length 122 Pages
SKU # LPI20085703

Description

The global Cell Cryoprotectant market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Cell cryoprotectants are substances used in cryopreservation to protect cells from damage caused by the formation of ice crystals during freezing. These compounds are added to the cells before freezing to prevent ice formation and minimize the harmful effects of extreme temperatures. Cryoprotectants act by reducing the freezing point of the intracellular and extracellular fluids, thus allowing cells to survive the freezing and thawing process with minimal damage. Common cryoprotectants include glycerol, dimethyl sulfoxide (DMSO), and ethylene glycol. The use of cryoprotectants is crucial in various fields, including cell biology, medicine, and assisted reproductive technologies, where the preservation of cell viability and functionality is essential for successful long-term storage.

Market in tissue and cell cryoprotectants indicate a growing demand for advanced cryopreservation solutions in the fields of regenerative medicine, biobanking, and cell therapy. The market is witnessing an increased focus on developing cryoprotectants that minimize cellular damage during freezing and thawing processes, enhancing cell viability and functionality. There is a notable shift towards animal-origin-free and chemically defined cryoprotectants to meet regulatory requirements and ensure product safety. The rise in stem cell research, organ transplantation, and personalized medicine is driving the adoption of cryopreservation techniques, fueling innovation in cryoprotectant formulations. As the biopharmaceutical and healthcare industries continue to expand, the tissue and cell cryoprotectant market is expected to experience sustained growth, with an emphasis on improving cryopreservation outcomes for various cell types and applications.

LP Information, Inc. (LPI) ' newest research report, the “Cell Cryoprotectant Industry Forecast” looks at past sales and reviews total world Cell Cryoprotectant sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Cryoprotectant sales for 2025 through 2031. With Cell Cryoprotectant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Cryoprotectant industry.

This Insight Report provides a comprehensive analysis of the global Cell Cryoprotectant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Cryoprotectant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Cryoprotectant market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Cryoprotectant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Cryoprotectant.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell Cryoprotectant market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Serum-containing Cryoprotectant
Serum-free Cryoprotectant

Segmentation by Application:
Biopharmaceutical
Scientific Research
Medical Beauty Industry
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
Cytiva
Zenogen Pharma
STEMCELL Technologies
FUJIFILM Wako Chemicals
R&D Systems
Promocell
Akron Biotechnology
Bulldog Bio
Miltenyi Biotec
Yocon Biology Technology
Solarbio Life Science
AMSBIO

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cell Cryoprotectant market?

What factors are driving Cell Cryoprotectant market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cell Cryoprotectant market opportunities vary by end market size?

How does Cell Cryoprotectant break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

122 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Cell Cryoprotectant by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Cell Cryoprotectant by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.